We’d love to hear your feedback on this activity. It helps us to continually improve our products.
IEC 2017 Day 3 highlights from Barcelona.
View Day 1 highlights here.
View Day 2 highlights here.
View Day 4 highlights here.
Content produced and shared with kind authorisation of the International Epilepsy Congress (IEC 2017).
In this interview with touchNEUROLOGY, Prof. Jacqueline French (Comprehensive Epilepsy Center, New York University, New York, NY, US) discusses the needs of adults with focal epilepsy and the mechanisms of action of XEN1101, a novel, potent, selective Kv7.2/7.3 potassium channel. The abstract entitled “XEN1101, a Novel Potassium Channel Modulator: Interim Data From an Ongoing, Long-Term, […]
The randomized, double-blind, placebo-controlled phase IIb study X-TOLE (NCT03796962) is investigating the efficacy of XEN1101, a novel potassium channel modulator, in adults with focal epilepsy. In this interview with touchNEUROLOGY, Prof. Jacqueline French (Comprehensive Epilepsy Center, New York University, New York, NY, US) discusses this clinical trial and the outcomes of its open-label extension. The […]
Get the latest clinical insights from touchNEUROLOGY